OMER FY 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$112M+274.3% YoY

Gross Profit

$109M97.6% margin

Operating Income

-$63M-56.7% margin

Net Income

-$84M-75.6% margin

EPS (Diluted)

$-2.16

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$60M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$137M

Total Liabilities

$246M

Stockholders' Equity

-$109M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$30M	+274.3%
Gross Profit	$109M	$29M	+271.8%
Operating Income	-$63M	-$112M	+43.5%
Net Income	-$84M	-$127M	+33.3%